Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes have?
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes has 666 citations in the OpenAlex counts ScholarIQ stores.
When was Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes published?
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes has 2024 year in the ScholarIQ index.
What is the open-access status of Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes?
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes has green oa status in the ScholarIQ index.
What is the DOI of Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes?
The DOI for Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes is on the source record.
What is the PMID of Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes?
The PMID for Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes is on the source record.
What is the OpenAlex record for Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes?
The OpenAlex for Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes is on the source record.